Limiting the use of such agents may help decrease the spread of VRE.
In this context, it is important to remind that the majority of patients with hemorrhagic shock require the use of such agents to obtain analgesia or sedation for ventilatory intubation during shock management or before surgical intervention or embolization.
Moreover, many processes involved in adhesion formation are also part of normal wound healing, so any pharmacological agent needs to reduce fibrin deposition, yet still allow for re-epithelialisation. Research continues on a range of pharmacological agents but they are still at an experimental stage and the practical use of such agents in routine surgery is some way off.
Perhaps surprisingly, such treatment recommendations or guidelines do not yet exist for ocular toxoplasmosis the most common cause of infectious uveitis worldwide [30, 31], and while guidelines do exist regarding the use of immunosuppressive drugs in patients with noninfectious uveitis, they are largely unknown by all but those already quite experienced in the use of such agents.
Despite the apparent usefulness of systemic IMT in the management of uveitis, bone marrow suppression, neurotoxicity, nephrotoxicity, hepatitis, pneumonitis, diarrhea, infertility, and secondary malignancy are potential side effects that limit the use of such agents and require individualization and close monitoring of IMT [9].
To the extent to which model organisms can be used to identify supposedly beneficial substances for medical or other uses, they perforce must also be of value in raising questions about the use of such agents, questions that may be directed at either the supposed benefits of such agents or their chronic side effects.
Therefore, the use of such agent simultaneously with other compounds, compared with the sequential administration of the same agents, would result in different cytotoxic effects (Fu et al, 1999).
He used hundreds of such agents.
One might anticipate that the use of any such agents in situ will require methodologies for cell-specific delivery and regulated dose and/or function to avoid perturbing the natural balance of other miRNA-mediated effects on the transcriptome.
One intelligence official said then that American teams in Afghanistan had collected the bones of small animals and taken soil samples that proved to have traces consistent with the use of such chemical agents.
It should be emphasized that the use of such persistent agents into the human spinal canal must be subject to extensive preclinical safety evaluation [49], [50].
